Literature DB >> 16823386

Effects of tianeptine on onset time of pentylenetetrazole-induced seizures in mice: possible role of adenosine A1 receptors.

Tayfun I Uzbay1, Hakan Kayir, Mert Ceyhan.   

Abstract

Depression is a common psychiatric problem in epileptic patients. Thus, it is important that an antidepressant agent has anticonvulsant activity. This study was organized to investigate the effects of tianeptine, an atypical antidepressant, on pentylenetetrazole (PTZ)-induced seizure in mice. A possible contribution of adenosine receptors was also evaluated. Adult male Swiss-Webster mice (25-35 g) were subjects. PTZ (80 mg/kg, i.p.) was injected to mice 30 min after tianeptine (2.5-80 mg/kg, i.p.) or saline administration. The onset times of 'first myoclonic jerk' (FMJ) and 'generalized clonic seizures' (GCS) were recorded. Duration of 600 s was taken as a cutoff time in calculation of the onset time of the seizures. To evaluate the contribution of adenosine receptors in the effect of tianeptine, a nonspecific adenosine receptor antagonist caffeine, a specific A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a specific A2A receptor antagonist 8-(3-chlorostyryl) caffeine (CSC) or their vehicles were administered to the mice 15 min before tianeptine (80 mg/kg) or saline treatments. Tianeptine (40 and 80 mg/kg) pretreatment significantly delayed the onset time of FMJ and GCS. Caffeine (10-60 mg/kg, i.p.) dose-dependently blocked the retarding effect of tianeptine (80 mg/kg) on the onset times of FMJ and GCS. DPCPX (20 mg/kg) but not CSC (1-8 mg/kg) blocked the effect of tianeptine (80 mg/kg) on FMJ. Our results suggest that tianeptine delayed the onset time of PTZ-induced seizures via adenosine A1 receptors in mice. Thus, this drug may be a useful choice for epileptic patients with depression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16823386     DOI: 10.1038/sj.npp.1301143

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  15 in total

1.  Formulation of a novel tianeptine sodium orodispersible film.

Authors:  Doaa Ahmed El-Setouhy; Nevine Shawky Abd El-Malak; Nevine Shawky Abd El-Malak
Journal:  AAPS PharmSciTech       Date:  2010-06-08       Impact factor: 3.246

2.  Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A₁ and A2A receptor activation.

Authors:  Mauricio P Cunha; Francis L Pazini; Julia M Rosa; Ana B Ramos-Hryb; Ágatha Oliveira; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2015-02-22       Impact factor: 3.765

3.  Opioid-like adverse effects of tianeptine in male rats and mice.

Authors:  T R Baird; H I Akbarali; W L Dewey; H Elder; M Kang; S A Marsh; M R Peace; J L Poklis; E J Santos; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2022-02-24       Impact factor: 4.530

Review 4.  Adenosine receptors and epilepsy: current evidence and future potential.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

5.  Analysis of flurothyl-induced myoclonus in inbred strains of mice.

Authors:  Dominick Papandrea; Whitney S Kukol; Tara M Anderson; Bruce J Herron; Russell J Ferland
Journal:  Epilepsy Res       Date:  2009-09-09       Impact factor: 3.045

Review 6.  Serotonin and sudden unexpected death in epilepsy.

Authors:  Alexandra N Petrucci; Katelyn G Joyal; Benton S Purnell; Gordon F Buchanan
Journal:  Exp Neurol       Date:  2019-12-19       Impact factor: 5.330

7.  Anticonvulsant activity of B2, an adenosine analog, on chemical convulsant-induced seizures.

Authors:  Min Li; Ruixia Kang; Jiangong Shi; Gengtao Liu; Jianjun Zhang
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

8.  The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist.

Authors:  M M Gassaway; M-L Rives; A C Kruegel; J A Javitch; D Sames
Journal:  Transl Psychiatry       Date:  2014-07-15       Impact factor: 6.222

9.  Pharmacokinetic study of tianeptine and its active metabolite MC5 in rats following different routes of administration using a novel liquid chromatography tandem mass spectrometry analytical method.

Authors:  Małgorzata Szafarz; Agnieszka Wencel; Krzysztof Pociecha; Filip A Fedak; Piotr Wlaź; Elżbieta Wyska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-12-12       Impact factor: 3.000

10.  Tianeptine: an antidepressant with memory-protective properties.

Authors:  Phillip R Zoladz; Collin R Park; Carmen Muñoz; Monika Fleshner; David M Diamond
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.